ATRC stock news · AtriCure, Inc.

Stories about AtriCure, Inc. (ATRC) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ATRC

Follow AtriCure, Inc. (ATRC) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 4, 2026, 5:42 AM ET · Opinion
AtriCure made 17 cents per share last quarter, surprising analysts and prompting them to raise their price targets.
Good or bad for ATRC?
Nov 3, 2026, 6:51 PM ET · Market
AtriCure's sales grew 15% last quarter to $154.5 million, with a profit of $4.1 million.
Good for ATRC
AtriCure reported $154.5 million in third-quarter sales, up 15%, and earned $4.1 million after a year-earlier loss. This points to improving business despite weaker minimally invasive ablation sales.
Nov 3, 2026, 5:45 PM ET · Market
AtriCure's sales grew 15% to $154.5 million last quarter, thanks to strong growth in the U.S.
Good for ATRC
AtriCure's Q3 sales rose 15% to $154.5 million, and it forecast $606 million to $610 million in 2026 sales. Sales growth and quarterly profit make this encouraging.
Sep 2, 2026, 8:45 AM ET · Market
Could Salesforce Surge Over 16%? Discover 10 Leading Analyst Predictions for Wednesday.
Good for ATRC
Needham raised AtriCure's price target and kept a Buy rating, a constructive sign for the equity.